ADAM12 Is Selectively Overexpressed in Human Glioblastomas and Is Associated with Glioblastoma Cell Proliferation and Shedding of Heparin-Binding Epidermal Growth Factor
Open Access
- 1 November 2004
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 165 (5) , 1743-1753
- https://doi.org/10.1016/s0002-9440(10)63429-3
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Adam12 in Human Liver Cancers: Tgf–β–Regulated Expression in Stellate Cells Is Associated With Matrix RemodelingHepatology, 2003
- Phenotypic Analysis of Meltrin α (ADAM12)-Deficient Mice: Involvement of Meltrin α in Adipogenesis and MyogenesisMolecular and Cellular Biology, 2003
- Intracellular Processing of Metalloprotease Disintegrin ADAM12Journal of Biological Chemistry, 2002
- Increased syndecan expression by pleiotrophin and FGF receptor‐expressing astrocytes in injured brain tissueGlia, 2002
- ADAM 12-S Cleaves IGFBP-3 and IGFBP-5 and Is Inhibited by TIMP-3Biochemical and Biophysical Research Communications, 2000
- Primary and secondary glioblastomas: From concept to clinical diagnosisNeuro-Oncology, 1999
- An Essential Role for Ectodomain Shedding in Mammalian DevelopmentScience, 1998
- A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cellsNature, 1997
- A tiger behind many doors: multiple genetic pathways to malignant gliomaTrends in Genetics, 1995
- Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumorsJournal of Neurosurgery, 1994